Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines

Genomics

Volumn 70, Issue 1, 2000, Pages 113-122

  Fong, Wai Gin ^a   Liston, Peter ^b   Rajcan Separovic, Evica ^c   St Jean, Martine ^d   Craig, Constance ^d   Korneluk, Robert G ^a,d  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA REGIONAL CANCER CENTRE   (Canada)

^c BC CHILDREN S HOSPITAL   (Canada)

^d Aegera Therapeutics Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 9; PROTEINASE; ZINC FINGER PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL DEATH; CHROMOSOMAL LOCALIZATION; EXON; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; TELOMERE; X CHROMOSOMAL INHERITANCE;

EID: 0034672506     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.2000.6364     Document Type: Article

References (36)

1. Functional evidence for a breast cancer growth suppressor gene on chromosome 17
2. The IAP genes: Unique arbitrators of cell death
3. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations
4. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases
5. IAP family proteins - Suppressors of apoptosis
6. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases
7. X-linked IAP is a direct inhibitor of cell-death proteases
8. A comprehensive genetic map of the human genome based on 5,264 microsatellites
9. High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers
10. Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer
11. Drosophila homologs of baculovirus inhibitor of apoptosis proteins function to block cell death
12. Real time quantitative PCR
13. Preparation of yeast DNA, RNA and proteins
14. Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers
15. The inhibitors of apoptosis (IAPs) and their emerging role in cancer
16. DNA methylation and cancer
17. Identification of XAF1 as an antagonist of XIAP anticaspase activity
18. Life and death: The role of the IAPs in modulating programmed cell death
19. Quantitative analysis of aberrent p16 methylation using real-time quantitative methylation-specific polymerase chain reaction
20. Gene silencing in the development of cancer
21. Fine mapping of the cystinosis gene using an integrated genetic and physical map of a region with human chromosome band 17p13
22. Loss of heterozygosity on chromosome 17p13 in breast carcinomas identifies tumors with high proliferation index
23. Allelic loss on chromosome 17 in human ovarian cancer
24. Allelic deletion on chromosome 17p13.3 in early ovarian cancer
25. Molecular genetic studies in medulloblastomas: Evidence for tumor suppressor genes at the chromosomal regions 1q31-32 and 17p13
26. Assignment of human inhibitor of apoptosis (IAP) genes xiap, hiap-1, and hiap-2 to chromosomes Xq25 and 11q22-q23 by fluorescence in situ hybridization
27. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins
28. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
29. Does this have a familiar RING?
30. Cloning and localization of a human diphthamide biosynthesis-like protein-2 gene, DPH2L2
31. Identification of two candidate tumor suppressor genes on chromosome 17p13.3
32. Deletion mapping on chromosome 17p in medulloblastoma
33. A single BIR domain of XIAP sufficient for inhibiting caspases
34. Expression and prognostic significance of IAP-family of genes in human cancers and myeloid leukemias
35. p53 activates expression of HIC-1, a new candidate tumor suppressor gene on 17p13.3
36. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation